,i #aafth ,,congress #ast ,session ,h4 ,r4 #dbdd ,,in ,,the ,,house ,,of ,,representatives ,september #i1 #bjai,mr4 ,kelly of ,pennsylvania introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to provide for a pathway for chemically synthesized insulin to be approved under an abbreviated new drug application submitted under the ,federal ,food1 ,drug1 and ,cosmetic ,act1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,market ,access for ,generic ,insulin ,competition or the ,,magic ,act4 #b4 ,providing for a pathway for approval of chemically synthesized insulin under an abbreviated new drug application 7a7 ,in general ,section #gjjb7;e77#b7 of the ,patient ,protection and ,affordable ,care ,act 7#db ,u4,s4,c4 #bfb note7 is amended-- 7#a7 in subparagraph 7,b71 by redesignating clauses 7i7 and 7ii7 as subclauses 7,i7 and 7,,ii71 respectively1 and moving the margins of such subclauses 7as so redesignated7 two ems to the right2 7#b7 in subparagraph 7,a71 by striking such biological product and inserting 7i7 such biological product2 7#c7 by redesignating subparagraph 7,b7 as clause 7ii7 and moving the margin of such clause 7as so redesignated7 two ems to the right2 7#d7 in clause 7ii7 7as so redesignated71 by striking the period at the end and inserting 2 or2 and 7#e7 by adding at the end the following3 7,b7 notwithstanding paragraphs 7#c7 and 7#d71 the application is submitted under subsection 7j7 of such section for chemically synthesized insulin or any analogue of chemically synthesized insulin for which the listed drug is a biological product that is1 pursuant to paragraph 7#d71 deemed to be licensed under section #cea of the ,public ,health ,service ,act4 4 7b7 ,effective date ,the amendments made by this section shall apply with respect to applications submitted on or after ,january #a1 #bjbj4